NCT02752893已完成不适用
Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Xenograft success rate, defined as the percentage of patient tumors that yield a growing xenograft in mice.
研究概览
简要总结
The investigators will establish a platform at Dartmouth-Hitchcock Medical Center to generate novel models of estrogen receptor alpha-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, which will be used for research studies to develop novel treatment strategies and dissect signaling pathways underlying drug sensitivity and resistance.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Xenograft success rate, defined as the percentage of patient tumors that yield a growing xenograft in mice.
时间窗: 1 year from time of surgery
次要结局
未报告次要终点
研究者
Gary Schwartz
Staff Physician, Hematology-Oncology
Dartmouth-Hitchcock Medical Center
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast CancerBreast CancerNCT03573648Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins33
进行中（未招募）
2 期
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast CancersEstrogen Receptor Positive Breast CancerNCT02238808AHS Cancer Control Alberta19
已完成
不适用
earch for developing the breast cancer diagnostic method using photoacoustic mammographyBreast cancerJPRN-UMIN000003406Graduate School of Medicine Kyoto University40
招募中
不适用
A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted TherapiesHER2-positive Breast CancerNCT04288141King's College London40
已完成
不适用
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal DatabaseBreast CancerNCT01937052Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins329